Application of marker vaccines against livestock diseases. | Semantic Scholar
Immuno | Free Full-Text | Rescuing Immunosenescence via Non-Specific Vaccination
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Application of marker vaccines against livestock diseases. | Semantic Scholar
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | PNAS
marker vaccine - List of Frontiers' open access articles
Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | Nature
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 - eBioMedicine
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
Understanding which IBR vaccine to use in your herd
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
Experiences With Two BHVl Marker-Vaccines
Infectious bovine rhinotracheitis (IBR) marker vaccines available in... | Download Table
Factors That Influence the Immune Response to Vaccination | Clinical Microbiology Reviews
Vaccine - Wikipedia
The how's and what's of vaccine reactogenicity | npj Vaccines
PDF) An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field | Jan van Oirschot - Academia.edu
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
